Use of Monoclonal Antibodies in Pregnant Women Infected by COVID-19: A Case Series

Use of Monoclonal Antibodies in Pregnant Women Infected by COVID-19: A Case Series

Background: Monoclonal antibodies are designed to target specific proteins of COVID-19 and can be used as a treatment for people with mild to moderate infection and at a high risk of severe disease. Casirivimab/imdevimab, sotrovimab, and Bamlanivimab/etesevimab have been authorized for emergency use...

Full description

Bibliographic Details
Main Authors: Pietro Crispino, Raffaella Marocco, Daniela Di Trento, Gloria Guarisco, Blerta Kertusha, Anna Carraro, Sara Corazza, Cristina Pane, Luciano Di Troia, Cosimo del Borgo, Miriam Lichtner
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Microorganisms
Subjects:
COVID-19
pregnancy
monoclonal antibody (Mabs)
Online Access:https://www.mdpi.com/2076-2607/11/8/1953

Internet

https://www.mdpi.com/2076-2607/11/8/1953

Similar Items